Welcome to our dedicated page for Kronos Worldwide SEC filings (Ticker: KRO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kronos Worldwide, Inc. (NYSE: KRO) SEC filings page on Stock Titan brings together the company’s regulatory disclosures, including Forms 8-K and other key documents filed with the U.S. Securities and Exchange Commission. These filings provide detailed information about the titanium dioxide producer’s financial condition, capital structure, risk factors and corporate actions.
Recent Form 8-K filings from Kronos Worldwide furnish earnings press releases that discuss quarterly net income or loss, TiO2 segment profit, EBITDA and drivers such as sales volumes, average TiO2 selling prices, product mix, production volumes, fixed cost absorption, distribution and warehousing costs, and currency exchange rates. These documents also include forward-looking statements and extensive risk factor summaries that explain how tariffs, trade policies, global economic conditions, raw material and energy costs, and competition can affect future results.
Other 8-K filings describe material definitive agreements and financing transactions, such as the institutional private placement of additional euro-denominated 9.50% senior secured notes due 2029 issued by Kronos International, Inc., a wholly owned subsidiary. These filings outline the principal terms of the notes, related guarantees and collateral, permitted covenants, redemption options and the intended use of proceeds, including repayment of existing senior secured notes at maturity and general corporate purposes.
Kronos Worldwide also uses Form 8-K to report dividend declarations, board and executive changes, and annual meeting results, giving investors insight into governance and capital allocation decisions. Over time, Forms 10-K, 10-Q, 8-K and any proxy statements collectively provide a regulatory history of the company’s titanium dioxide operations, liquidity management and risk profile.
On Stock Titan, these filings are updated as they are made available on EDGAR, and AI-powered summaries help explain the significance of complex items such as non-GAAP measures, debt covenants, and risk factor updates, allowing readers to review the core points of each Kronos Worldwide filing more efficiently.
Kronos Worldwide, Inc. reported a first quarter 2026 net loss of $4.8 million, or $0.04 per share, reversing net income of $18.1 million, or $0.16 per share, a year earlier. Net sales rose to $509.8 million from $489.8 million, a 4% increase driven mainly by higher TiO₂ sales volumes in North America, Latin America and export markets and favorable currency movements, partially offset by lower prices and weaker European volumes.
Income from operations fell to $12.6 million from $38.4 million as lower average TiO₂ selling prices and reduced production volumes outweighed higher volumes and lower production costs from 2025 cost reduction initiatives and lower raw material and energy costs. TiO₂ segment profit declined to $15.1 million from $41.6 million, and EBITDA dropped to $27.7 million from $51.2 million. Management highlighted a $74.5 million sequential improvement in segment profit versus the fourth quarter of 2025 after restructuring actions, while noting a $2.0 million tax expense related to an uncertain German tax position.
Kronos Worldwide, Inc. reported a small net loss in the first quarter of 2026 as softer pricing outweighed higher volumes and cost savings. Net sales rose to $509.8 million from $489.8 million, driven by a 4% increase in TiO₂ sales volumes and favorable currency movements, partly offset by a 6% decline in average TiO₂ selling prices.
Gross margin narrowed to 16% of sales from 22% as lower prices and higher reported cost of sales more than offset lower production costs and reduced unabsorbed fixed costs. The company posted a net loss of $4.8 million, or $(0.04) per share, versus net income of $18.1 million, or $0.16 per share, a year earlier, including $2.0 million of income tax expense for an uncertain German tax position. Operating cash outflow improved to $51.3 million from $102.4 million as inventories declined, while long-term debt increased to $602.7 million, supported by Global Revolver availability of about $287 million.
Kronos Worldwide, Inc. is calling its 2026 annual stockholder meeting for May 13, 2026 in Dallas to elect eight directors and hold a nonbinding Say‑on‑Pay vote on executive compensation. Only holders of common stock at the March 17, 2026 record date may vote, with 115,053,116 shares outstanding.
Valhi and NLKW together own about 81.0% of the common stock and have indicated they will vote for all director nominees and for Say‑on‑Pay, effectively determining the outcomes and ensuring a quorum. Kronos is a NYSE “controlled company” and uses that status to forgo a separate nominating committee.
Executive officers, including CEO Brian W. Christian, are employed by Contran and provided under an intercorporate services agreement. In 2025 Kronos paid Contran about $25.8 million for these shared services, and the listed executive “salary” amounts (for example, $2,293,000 for former CEO James M. Buch in 2025) reflect Kronos’ allocated portion of Contran’s costs rather than direct payroll. Named executives receive no stock options or other equity awards, and there were no plan-based grants or option exercises in 2025. Non‑employee directors are paid cash retainers plus an annual stock grant worth about $20,000 and must maintain shareholdings equal to at least three times the base cash retainer.
Kronos Worldwide, Inc. reported a much deeper net loss of $82.8 million, or $.72 per share, in Q4 2025, versus a net loss of $13.2 million, or $.12 per share, in Q4 2024, as higher costs outweighed largely flat sales.
For full-year 2025, the company posted a net loss of $110.9 million, or $.96 per share, compared with net income of $86.2 million, or $.75 per share, in 2024. Net sales slipped 1% to $1.86 billion as higher TiO2 volumes could not offset lower selling prices.
Profitability weakened mainly due to about $111 million of unabsorbed fixed production costs from curtailments, lower average TiO2 prices, higher distribution and warehousing costs, workforce reduction charges of $10.3 million, a $9.0 million U.S. pension plan settlement loss, and non-cash German deferred tax expense of $19.3 million. EBITDA fell to $16.1 million in 2025 from $252.9 million in 2024, which had included a $64.5 million non-cash gain from the Louisiana Pigment Company acquisition.
Kronos Worldwide, Inc. reported a net loss of $110.9 million, or $.96 per share, for 2025, reversing net income of $86.2 million in 2024. Net sales slipped 1% to $1,859.4 million as titanium dioxide (TiO2) volumes rose 2% but average selling prices fell 4%.
Gross margin shrank to 11% from 19%, hurt by about $111 million of unabsorbed fixed production costs from operating rates cut to 77% of capacity, including a 55% rate in Q4. Higher warehousing and distribution costs, plus restructuring charges of roughly $10 million, further pressured results.
The company ended 2025 with total debt of about $557.4 million, including 9.50% senior secured notes due 2029, a term loan from Contran and borrowings under its global revolver. TiO2 still represented about 90% of net sales, with 45% of volumes sold into Europe and an estimated 15% European and 19% North American market share.
Kronos Worldwide, Inc. announced leadership changes and a cash dividend. Chief executive officer and director James M. Buch will retire effective February 27, 2026, including from officer roles at affiliate Contran Corporation. The board elected Brian W. Christian as a director and as president and chief executive officer, also effective February 27, 2026. Christian has held multiple senior roles at the company and related entities since 2006, including president since May 2025 and chief operating officer from 2023 to February 2026.
The board also declared a regular quarterly dividend of $0.05 per share on its common stock, payable on March 19, 2026 to stockholders of record at the close of business on March 10, 2026. Kronos describes itself as a major international producer of titanium dioxide products.
Kronos Worldwide, Inc. furnished a results update via Form 8-K. The company provided a press release under Item 2.02 (Results of Operations and Financial Condition), attached as Exhibit 99.1 and incorporated by reference as stated.
The company notes the furnished press release is not deemed “filed” for purposes of Section 18 of the Exchange Act and is not subject to Section 18 liabilities. Other SEC filings may incorporate this information only if expressly stated. Exhibits include 99.1 (Press Release) and 104 (Cover Page Inline XBRL data).
Kronos Worldwide (KRO) reported weaker results. Q3 2025 net sales were $456.9 million, down 6% year over year, with gross margin falling to 10% from 21%. The company posted a net loss of $37.0 million, versus $71.8 million of net income a year ago. Management cited lower TiO2 selling prices and reduced production rates that drove approximately $27 million of unabsorbed fixed costs in the quarter.
For the first nine months, net sales were $1.44 billion (down 2%) and net loss was $28.1 million. Operating cash flow used was $89.6 million, reflecting inventory positioning and lower absorption. Interest expense increased, and income tax expense includes a non-cash $19.3 million charge tied to Germany’s corporate tax rate reduction. Debt rose as KII issued an additional €75 million of 9.50% senior secured notes due 2029 to refinance 3.75% notes; long-term debt increased to $626.2 million, and the Global Revolver was upsized to $350 million with $70.2 million outstanding.
Kronos Worldwide, Inc. filed a Form 8-K to furnish information from a press release dated October 29, 2025. The company provides this disclosure under Regulation FD, attaching the release as Exhibit 99.1. The furnished information is not treated as filed for liability purposes or automatically incorporated into other SEC documents.